CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-17 | Dubovsky Filip President, R&D | Exercise or conversion | +1,404 | $6.97 | $10K | 68,017 |
| 2024-06-17 | Dubovsky Filip President, R&D | Exercise or conversion | +12,500 | $6.09 | $76K | 80,517 |
| 2024-06-17 | Dubovsky Filip President, R&D | Sale | −12,500 | $14.46 | $181K | 68,017 |
| 2024-06-17 | Dubovsky Filip President, R&D | Sale | −1,404 | $14.54 | $20K | 66,613 |
| 2024-06-17 | Dubovsky Filip President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −1,404 | $6.97 | $10K | 46,324 |
| 2024-06-17 | Dubovsky Filip President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −12,500 | $6.09 | $76K | 37,500 |
| 2024-05-14 | Dubovsky Filip President, R&D | Exercise or conversion | +19,652 | $6.97 | $137K | 86,265 |
| 2024-05-14 | Dubovsky Filip President, R&D | Sale | −47,312 | $13.90 | $658K | 38,953 |
| 2024-05-14 | Dubovsky Filip President, R&D | Exercise or conversion · Stock Option (Right to Buy) | −19,652 | 47,728 | ||
| 2024-03-10 | Dubovsky Filip President, R&D | Exercise or conversion | +5,376 | 69,210 | ||
| 2024-03-10 | Dubovsky Filip President, R&D | Shares withheld for taxes | −2,597 | $5.45 | $14K | 66,613 |
| 2024-03-10 | Dubovsky Filip President, R&D | Exercise or conversion · Restricted Stock Units | −5,376 | 5,376 | ||
| 2024-03-07 | Dubovsky Filip President, R&D | Exercise or conversion | +19,444 | 73,226 | ||
| 2024-03-07 | Dubovsky Filip President, R&D | Shares withheld for taxes | −9,392 | $5.61 | $53K | 63,834 |
| 2024-03-07 | Dubovsky Filip President, R&D | Exercise or conversion · Restricted Stock Units | −19,444 | 0 | ||
| 2024-03-01 | Dubovsky Filip President, R&D | Grant or award · Restricted Stock Units | +144,000 | 144,000 | ||
| 2023-12-14 | Dubovsky Filip President, R&D | Exercise or conversion | +2,833 | $5.69 | $16K | 55,150 |
| 2023-12-14 | Dubovsky Filip President, R&D | Shares withheld for taxes | −1,368 | $5.69 | $8K | 53,782 |
| 2023-12-14 | Dubovsky Filip President, R&D | Exercise or conversion · Restricted Stock Units | −2,833 | 0 | ||
| 2023-11-05 | Dubovsky Filip President, R&D | Exercise or conversion | +1,400 | $7.06 | $10K | 52,994 |
Page 1 of 2 · 28 trades